Merav Heshin-Bekenstein1, Laura Trupin2, Ed Yelin3, Emily von Scheven4, Jinoos Yazdany5, Erica F Lawson4. 1. Division of Pediatric Rheumatology, University of California San Francisco. Address: 550 16th Street, 5th Floor, San Francisco, CA 94143-0632, United States; Pediatric Rheumatology Clinic, Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Israel. Electronic address: meravhb@tlvmc.gov.il. 2. Rosalind Russell/Ephraim Engleman Rheumatology Research Center, University of California, San Francisco. Address: 513 Parnassus Avenue, Box 0500, United States. 3. Rosalind Russell/Ephraim Engleman Rheumatology Research Center, University of California San Francisco. Address: UCSF San Francisco, CA 94143-0920, United States. 4. Division of Pediatric Rheumatology, University of California San Francisco. Address: 550 16th Street, 5th Floor, San Francisco, CA 94143-0632, United States. 5. Division of Rheumatology, University of California San Francisco, 1001 Potrero Avenue, Building 30, San Francisco, CA 94110, United States.
Abstract
OBJECTIVES: Determine whether adults with childhood-onset systemic lupus erythematosus (cSLE) are at increased risk for disease- and steroid-related damage as compared to individuals with adult-onset SLE (aSLE), and whether they continue to accumulate disease damage in adulthood. METHODS: Data derive from the 2007-2015 cycles of the Lupus Outcomes Study, a longitudinal cohort of adults with confirmed SLE. The Brief Index of Lupus Damage (BILD), a validated, patient-reported measure, was used to assess SLE-associated damage. Participants with baseline BILD were included (N = 1035). Diagnosis at age < 18 years was defined as cSLE (N = 113). Outcome variables included BILD score at baseline and follow-up, clinically significant change in BILD score over follow-up period, and presence of steroid-related damage (cataracts, osteoporosis-related fracture, avascular necrosis or diabetes mellitus). RESULTS: Mean time between baseline and follow up BILD assessment was 6.3 ± 1.7 years. In adjusted analyses, participants with cSLE and aSLE had similar levels of disease-related damage, and accumulated damage at similar rates. Participants with cSLE were more likely to report steroid-related damage (OR 1.7, 95% CI 1.1-2.8) in the adjusted analysis as compared to those with aSLE. Likelihood of steroid-related damage increased with disease duration for both groups, but was consistently higher among cSLE participants. CONCLUSION: In this longitudinal cohort of adults with SLE, participants continued to accumulate damage at similar rates over time, regardless of age at onset or disease duration. Childhood-onset predicted increased risk of steroid-related damage. Aggressive use of steroid-sparing treatment strategies during childhood may be important to prevent steroid-related damage in adulthood.
OBJECTIVES: Determine whether adults with childhood-onset systemic lupus erythematosus (cSLE) are at increased risk for disease- and steroid-related damage as compared to individuals with adult-onset SLE (aSLE), and whether they continue to accumulate disease damage in adulthood. METHODS: Data derive from the 2007-2015 cycles of the Lupus Outcomes Study, a longitudinal cohort of adults with confirmed SLE. The Brief Index of Lupus Damage (BILD), a validated, patient-reported measure, was used to assess SLE-associated damage. Participants with baseline BILD were included (N = 1035). Diagnosis at age < 18 years was defined as cSLE (N = 113). Outcome variables included BILD score at baseline and follow-up, clinically significant change in BILD score over follow-up period, and presence of steroid-related damage (cataracts, osteoporosis-related fracture, avascular necrosis or diabetes mellitus). RESULTS: Mean time between baseline and follow up BILD assessment was 6.3 ± 1.7 years. In adjusted analyses, participants with cSLE and aSLE had similar levels of disease-related damage, and accumulated damage at similar rates. Participants with cSLE were more likely to report steroid-related damage (OR 1.7, 95% CI 1.1-2.8) in the adjusted analysis as compared to those with aSLE. Likelihood of steroid-related damage increased with disease duration for both groups, but was consistently higher among cSLE participants. CONCLUSION: In this longitudinal cohort of adults with SLE, participants continued to accumulate damage at similar rates over time, regardless of age at onset or disease duration. Childhood-onset predicted increased risk of steroid-related damage. Aggressive use of steroid-sparing treatment strategies during childhood may be important to prevent steroid-related damage in adulthood.
Authors: Dieneke Schonenberg-Meinema; Sandy C Bergkamp; Amara Nassar-Sheikh Rashid; Leontien B van der Aa; Godelieve J de Bree; Rebecca Ten Cate; Maurizio Cutolo; A Elisabeth Hak; Petra Ce Hissink Muller; Marieke van Onna; Taco W Kuijpers; Vanessa Smith; J Merlijn van den Berg Journal: Lupus Date: 2021-03-03 Impact factor: 2.911
Authors: Ana Luisa Rodríguez-Lozano; Francisco Eduardo Rivas-Larrauri; Silvestre García-de la Puente; Daniel Alfredo Alcivar-Arteaga; Alejandro Gabriel González-Garay Journal: Front Pediatr Date: 2022-04-22 Impact factor: 3.418
Authors: Eve M D Smith; Sarah L Gorst; Eslam Al-Abadi; Daniel P Hawley; Valentina Leone; Clarissa Pilkington; Athimalaipet V Ramanan; Satyapal Rangaraj; Arani Sridhar; Michael W Beresford; Bridget Young Journal: Rheumatology (Oxford) Date: 2021-12-01 Impact factor: 7.580
Authors: Nathalie E Chalhoub; Scott E Wenderfer; Deborah M Levy; Kelly Rouster-Stevens; Amita Aggarwal; Sonia I Savani; Natasha M Ruth; Thaschawee Arkachaisri; Tingting Qiu; Angela Merritt; Karen Onel; Beatrice Goilav; Raju P Khubchandani; Jianghong Deng; Adriana R Fonseca; Stacy P Ardoin; Coziana Ciurtin; Ozgur Kasapcopur; Marija Jelusic; Adam M Huber; Seza Ozen; Marisa S Klein-Gitelman; Simone Appenzeller; André Cavalcanti; Lampros Fotis; Sern Chin Lim; Rodrigo M Silva; Julia Ramírez- Miramontes; Natalie L Rosenwasser; Claudia Saad-Magalhaes; Dieneke Schonenberg-Meinema; Christiaan Scott; Clovis A Silva; Sandra Enciso; Maria T Terreri; Alfonso-Ragnar Torres-Jimenez; Maria Trachana; Sulaiman M Al-Mayouf; Prasad Devarajan; Bin Huang; Hermine I Brunner Journal: Arthritis Rheumatol Date: 2022-01-04 Impact factor: 10.995